So far, some clinical factors, such as alpha-fetoprotein (AFP), neutrophil-to-lymphocyte ratio (NLR), and serum gamma-glutamyl transpeptidase (GGT), have been put forward for the early detection, risk prediction, and monitoring use of HCC (7–9). The gene discussed is AFP; the disease is hepatocellular carcinoma.